Tuesday, May 24, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Assessing public trust and understanding of CDC’s revised COVID-19 guidelines

by Medical Finance
in Coronavirus
Study: Understanding of and Trust in the Centers for Disease Control and Prevention
10
SHARES
106
VIEWS
Share on FacebookShare on Twitter

In a  recent study published on the medRxiv* preprint server, researchers assess the understanding and trust of the revised coronavirus disease 2019 (COVID-19) isolation and quarantine guidance recommended by the United States Centers for Disease Control and Prevention (CDC) among U.S. adults.

Study: Understanding of and Trust in the Centers for Disease Control and Prevention

Study: Understanding of and Trust in the Centers for Disease Control and Prevention’s Revised COVID-19 Isolation and Quarantine Guidance Among US Adults. Image Credit: Rob Hainer / Shutterstock.com

The COVID-19 pandemic has caused an unprecedented loss of human life and resources all over the world. Isolation and quarantine guidelines have proved effective in reducing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. On December 27, 2021, a change in isolation and quarantine guidance for COVID-19-positive individuals was announced by the CDC, raising concerns regarding the scientific rationale of the revised guidelines.

About the study

An online survey of 603 participants was conducted between January 5, 2022, and January 6, 2022. The participants were grouped through nonprobability convenience sampling with individual characteristics that matched 2019 U.S. Census Data including age, ethnicity, race, and education. Informed consent of the participants was obtained electronically before the study began.

In the survey, the individuals answered questions based on comprehension of usage of isolation and quarantine guidances in hypothetical situations. Questions based on their personal history were called personal questions, whereas questions based on their vaccination history were referred to as scenario questions. Correlations between participant demographics and understanding of the provided passages were assessed with ordinal logistic regression.

Study findings

All four scenario and personal questions were correctly answered by 25% and 30% of the participants, respectively. A negative association in unvaccinated people and the number of questions they answered correctly was observed with an odds ratio of 0.74 and 0.61 for the scenario and the personal questions, respectively. Furthermore, not receiving a booster vaccine dose was also negatively associated with correctly answered personal questions with an odds ratio of 0.72.

Self-Reported Attitude Changes and Estimated Vaccine Effectiveness Against Hospitalization or Death from COVID-19 The graphs show (A) estimated effectiveness of a COVID-19 vaccine without a booster against hospitalization (orange bars) or death (gray bars), (B) estimated effectiveness of a COVID-19 vaccine with a booster against hospitalization (orange bars) or death (gray bars), and (C) the percentage of respondents who expressed changes in attitude before and after release of the revised guidance in response to three counterfactual questions.

Self-Reported Attitude Changes and Estimated Vaccine Effectiveness Against Hospitalization or Death from COVID-19 The graphs show (A) estimated effectiveness of a COVID-19 vaccine without a booster against hospitalization (orange bars) or death (gray bars), (B) estimated effectiveness of a COVID-19 vaccine with a booster against hospitalization (orange bars) or death (gray bars), and (C) the percentage of respondents who expressed changes in attitude before and after the release of the revised guidance in response to three counterfactual questions.

The participants guessed the effectiveness of the vaccine against COVID-19-related hospitalization to be in the range of 30% to 39% without a booster dose and between 70% to 79% after vaccination with a booster dose. Vaccine effectiveness against infection was perceived to be 75% and 35% with and without the administration of a booster dose, respectively.

Approximately 57% and 72% of the participants estimated the effectiveness of the vaccine against COVID-19-related death to be less than 90% with and without booster vaccination, respectively.  

After the revision of the CDC guidelines was announced, counterfactual questions showed that 26% of participants expressed reduced trust in the CDC recommendations, while 28% had reduced confidence in the organization’s scientific rationale regarding COVID-19 guidelines. Furthermore, 44% of participants believed that economic factors significantly affected CDC’s guidelines.

Conclusions

Based on the study findings, widespread knowledge gaps were observed in the understanding of the CDC’s revised isolation and quarantine guidance among U.S. adults. The negative correlation between the vaccination status of the participants and their comprehension scores indicated that the guidelines might be least available to individuals at higher risk of COVID-19 infection. Counterfactual questions revealed a significant reduction in public trust towards the CDC, owing to the belief that economic changes influenced the CDC’s recommendations.

More clarity in COVID-19-related information and improved responsiveness in public health announcements by the CDC will play a crucial role in keeping the public informed about the pandemic, as well as limiting the spread and severity of the disease.    

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Magnetic nanoparticles for SARS-CoV-2 and other virus detection systems

Magnetic nanoparticles for SARS-CoV-2 and other virus detection systems

by Medical Finance
May 24, 2022
0

The incorporation of nanotechnology into medicine revolutionized both diagnostic and therapeutic technologies by enhancing their sensitivity and specificity capabilities. In...

Study: Immune response to third SARS-CoV-2 vaccination in seronegative kidney transplant recipients: possible improvement by mycophenolate mofetil reduction. Image Credit: NIAID

Response to COVID-19 vaccine booster in seronegative kidney transplant recipients

by Medical Finance
May 24, 2022
0

Immunization is considered the most important and efficient strategy for preventing severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). However,...

Study: The major genetic risk factor for severe COVID-19 is associated with protection against HIV. Image Credit: IR Stone / Shutterstock

Neanderthal gene makes people susceptible to COVID-19, but protects against HIV

by Medical Finance
May 24, 2022
0

A study recently published in the top-tier journal Proceedings of the National Academy of Sciences of the United States of...

Officials struggle to regulate pop-up covid testing sites — and warn patients to beware

The demise of single-payer in California trips up efforts in other states

by Medical Finance
May 24, 2022
0

Single-payer health care didn't stand a chance in California this year. Even in this deep-blue bastion, Democratic lawmakers shied away...

Study: Cell-mediated and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients. Image Credit: Carl DMaster/Shutterstock

Humoral and cellular response to primary and booster COVID-19 vaccination in immunosuppressed patients

by Medical Finance
May 24, 2022
0

Recently, researchers posted the results of a retrospective observational cohort study to the medRxiv* preprint server in which they...

Study: Inhalable SARS-CoV-2 Mimetic Particles Induce Pleiotropic Antigen Presentation. Image Credit: Josep Suria/Shutterstock

Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

by Medical Finance
May 24, 2022
0

Macrophages play a crucial part in inducing both innate and adaptive immunity in the human body. Their major roles include...

Next Post
Study: Engineering a Vaccine Platform using Rotavirus A to Express SARS-CoV-2 Spike Epitopes. Image Credit: Kateryna Kon/Shutterstock

Engineering rotavirus-based vaccine vectors expressing SARS-CoV-2 spike epitopes

Bruker introduces Ultima Investigator Plus — Multiphoton microscope for tissue imaging

Bruker introduces Ultima Investigator Plus — Multiphoton microscope for tissue imaging

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • SARS-CoV-2
    COVID-19 and the life sciences; What have we learned?
  • Gene 620x480
    Experts develop new method to control gene expression using electrical signals
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply